Literature DB >> 8834330

Unexpected lung lesions in high resolution computed tomography (HRTC) among patients with advanced HIV disease.

S A Guillemi1, C A Staples, J C Hogg, A N Le, L M Lawson, M T Schechter, J S Montaner.   

Abstract

The present pilot study was undertaken to characterize the frequency of lung lesions in asymptomatic human deficiency virus (HIV) infected individuals with advanced HIV disease. Thirty two consecutive HIV+ homosexual males assessed for initiation of Pneumocystis carinii pneumonia (PCP) prophylaxis, were prospectively studied. All patients underwent a complete medical history, physical examination, pulmonary function tests and high resolution computed tomography (HRCT). HRCT scans were read by a single radiologist, who was blind as to the clinical status of the patient. Unexpected HRCT scan lesions were found in 60% of patients. There were no statistically significant differences between patients with normal and abnormal HRCT with respect to age, height, weight, CD4+ count, smoking history, serum albumin, alpha 1-antitrypsin level or body mass index. Forced vital capacity (FVC) (% of predicted) and peak expiratory flow rate (PEFR) (% pred) were not significantly different between groups. For patients with normal and abnormal HRCT forced expiratory volume in one second (FEV1) (% pred) was 99 +/- 12 vs 92 +/- 16, FEV1/FVC was 82 +/- 5 vs 76 +/- 9, and forced mid-expiratory flow (FEF25-75) (% pred) was 100 +/- 24 vs 77 +/- 27, respectively. There were no statistically significant differences between patients presenting with destructive versus nondestructive lung HRCT lesions. Our results demonstrate that as many as 60% of HIV-infected patients have unexpected abnormalities on HRCT at the time of starting PCP prophylaxis. We speculate that these lesions may contribute to the high frequency of spontaneous pneumothoraces previously reported in this patient population.

Entities:  

Mesh:

Year:  1996        PMID: 8834330     DOI: 10.1183/09031936.96.09010033

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  5 in total

Review 1.  Inhaled transmembrane ion transport modulators and non-steroidal anti-inflammatory drugs in asthma.

Authors:  S Bianco; M Robuschi; A Vaghi; A Fumagalli; P Sestini
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

2.  Risk Factors Associated With Quantitative Evidence of Lung Emphysema and Fibrosis in an HIV-Infected Cohort.

Authors:  Joseph K Leader; Kristina Crothers; Laurence Huang; Mark A King; Alison Morris; Bruce W Thompson; Sonia C Flores; Michael B Drummond; William N Rom; Philip T Diaz
Journal:  J Acquir Immune Defic Syndr       Date:  2016-04-01       Impact factor: 3.731

Review 3.  Bronchiectasis and other chronic lung diseases in adolescents living with HIV.

Authors:  Engi F Attia; Robert F Miller; Rashida A Ferrand
Journal:  Curr Opin Infect Dis       Date:  2017-02       Impact factor: 4.915

4.  Increased risk of radiographic emphysema in HIV is associated with elevated soluble CD14 and nadir CD4.

Authors:  Engi F Attia; Kathleen M Akgün; Cherry Wongtrakool; Matthew Bidwell Goetz; Maria C Rodriguez-Barradas; David Rimland; Sheldon T Brown; Guy W Soo Hoo; Joon Kim; Patty J Lee; Lynn M Schnapp; Amir Sharafkhaneh; Amy C Justice; Kristina Crothers
Journal:  Chest       Date:  2014-12       Impact factor: 9.410

Review 5.  Interactions between HIV infection and chronic obstructive pulmonary disease: Clinical and epidemiological aspects.

Authors:  Christine Raynaud; Nicolas Roche; Christos Chouaid
Journal:  Respir Res       Date:  2011-09-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.